期刊文献+

IGF-Ⅰ、IGF-ⅠR、IGF-Ⅱ在结直肠腺瘤中的表达及意义

Significance of expression of IGF- I, IGF-I R and IGF-II in colorectal adenoma
下载PDF
导出
摘要 目的:探讨胰岛素样生长因子(insulin—like growth factor,IGF)-I、IGF-IR、IGF-II在结直肠腺瘤中的表达及意义方法:选取2011-01/2013—06在我院内镜中心行电子结肠镜检查并经活检病理确诊的100例结直肠腺瘤(colorectal adenoma,CRA),30例结直肠癌(colorectal cancer,CRC),30例炎性息肉,同期20例正常结直肠黏膜作为阴性对照组:应用免疫组织化学SP法检测IGF—I、IGF—IR、IGF—II的表达.结果:IGF—I、IGF.IR、IGF—II的阳性表达在正常结直肠黏膜组(5.0%、10.0%、10.0%)与炎性息肉组f6.7%、10.0%、10.0%)无统计学差异(P〉0.05),正常结直肠黏膜组和炎性息肉组与CRA组(36.0%、48.0%、44.0%、、CRC组(63.3%、80.0%、73.3%)比较呈逐渐增加趋势,差异有明显统计学意义(P〈0.01);在CRA组,IGF—I、IGF—IR、IGF—II的阳性表达与性别、年龄、数量、部位均无明显关系(P〉0.05),与腺瘤大小、增生程度、组织学分类有显著统计学差异(P〈0.01):在CRA组,IGF—I、IGF—IR、IGF—II的表达相互间呈正相关(P〈0.01).结论:在正常人群的结、直肠黏膜向腺瘤的转化,以及腺瘤的增长和转化过程中,IGFs和IGFs—R轴发挥着极其重要作用,因CLIGF-I、IGF-IR、IGF-II有可能作为结肠腺瘤癌变的预测指标,对临床早期诊治具有重要意义. AIM: To explore the significance of expression of insulin-like growth factor (IGF)- I, IGF- I receptor (IGF- I R) and IGF- II in colorectal adenoma. METHODS: Specimens were collected from 100 patients with colorectal adenoma (CRA), 30 patients with colorectal cancer (CRC) and 30 patients with inflammatory polyps who underwent colonoscopy and pathological biopsy at Boai Hospital from January 2011 to June 2013. Twenty cases of normal colorectal mucosa were usedas a negative control group. Expression of IGF- I, IGF- I R, and IGF-II in the specimens was detected by immunohistochemical SP method. RESULTS: There were no significant differences in the positive rates of IGF- I, IGF- I R and IGF- II expression between the normal colorectal mucosa group and inflammatory polyps group (5.0% vs 6.7%, 10.0% vs 10.0%, 10.0% vs 10.0%, P 〉 0.05 for all); however, significant differences were observed in the normal colorectal mucosa group and inflammatory polyps group when compared with the CRA group (36.0%, 48.0%, 44.0%) and CRC group (63.3%, 80.0%, 73.3%) (P 〈 0.01 for all). In the CRA group, the positive expression of IGF- I, IGF- I R and IGF-II was significantly correlated with adenoma size, hyperplastic degree and histological classification (P 〈 0.01 for all), but not with gender, age, number, or site of the adenoma (P 〉 0.05 for all). In the CRA group, there were positive correlations between the expression of IGF- I, IGF- I R and IGF- II (P 〈 0.01 for all). CONCLUSION: The IGFs/IGFs-R axis plays an important role in the transformation of normal colorectal mucosa to adenoma and in growth and transformation of the adenoma. IGF- I, IGF- I R and IGF-II can be used as predictive indices for malignant transformation of colorectal adenoma.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第5期724-729,共6页 World Chinese Journal of Digestology
基金 中山市科技局基金资助项目,No.20113A124
关键词 结直肠腺瘤 胰岛素样生长因子I 胰岛素样生长因子II 胰岛素样生长因子I受体 免疫组织化学 Colorectal Adenoma Insulin-like growthfactor I Insulin-like growth factor II Insulin-likegrowth factor I receptor Immunohistochemistry
  • 相关文献

参考文献18

  • 1万德森.我国结直肠癌的流行趋势及对策[J].中华肿瘤杂志,2011,33(7):481-483. 被引量:125
  • 2崔艳欣,姜常青,王瑶,姜相君,辛永宁,宋明全.结直肠腺瘤患者血清IGF-1和IGFBP-3的变化及其临床意义[J].世界华人消化杂志,2012,20(26):2529-2533. 被引量:7
  • 3Roddam Alien NE, appleby P, Key TJ, Fer- rucci L, Carter HB, Metter EJ, Chen C, Weiss iNS, Fitzpatrick A, Hsing AW, Lacey JV, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schr?der FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Jo- hansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospectivestudies. Ann Intern Med 2008; 149: 461-471, W83-W88 [PMID:18838726 DOI:10.7326/000 3-4819-149-7-200810070-00006].
  • 4Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11:530-542 [PMID: 20472501].
  • 5Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Pani- co S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E, Donate Su:rez I, Barricarte Gurrea A, Gonzalez CA, Tormo MJ, Altzibar JM, Olsen A, Tjonneland A, Gronbaek H, Overvad K, Clavel- Chapelon F, Boutron-Ruault MC, Morois S, Slimani N, Boffetta P, Jenab M, Riboli E, Kaaks R. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 2010; 126: 1702-1715 [PMID: 19810099 DOI: 10.1002/ijc.24927].
  • 6Cui H. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis Markers 2007; 23:105-112 [PMID: 17325430].
  • 7何晶晶,黄甜,刘丽,向浩,刘莉,许奕华,魏晟,张肖肖,陈继贵,王倩,刘畅,聂绍发.结直肠癌组织IGF-ⅠR和IGF-Ⅰ与IGF-Ⅱ表达及其意义的研究[J].中华肿瘤防治杂志,2008,15(13):976-980. 被引量:11
  • 8赵凯,范钰,沈琰,李新忠,张小平IGF-Ⅱ、IGF-1R在结肠腺瘤中的表达及其生物学意义陕两医学杂志2009;38:1475.1477.
  • 9Tao Y, Pinzi V, Bourhis J, Deutsch E. Mechanisms of disease: signaling of the insulin-like growth fac- tor 1 receptor pathway-therapeutic perspectives in cancer. Nat Clin Pract Oncol 2007; 4:591-602 [PMID: 17898809 DOI: 10.1038/ncponc0934].
  • 10Jelinic P, Shaw P. Loss of imprinting and cancer. J Pathol 2007; 211:261-268 [PMID: 17177177 DOI: 10.lO02/path.2116].

二级参考文献78

共引文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部